PostersParallel Session: Late-Breaker Oral Presentations1413 SIMEPREVIR (TMC435) WITH PEGINTERFERON/RIBAVIRIN FOR TREATMENT OF CHRONIC HCV GENOTYPE-1 INFECTION IN TREATMENT-NAÏVE PATIENTS: RESULTS FROM QUEST-2, A PHASE III TRIAL
Parallel Session: Late-Breaker Oral Presentations
References (0)
Cited by (0)
Copyright © 2013 Elsevier B.V. and European Association for the Study of the Liver. All rights reserved.